Effect of iron and phagocytosis on murine macrophage activation in vitro.
Iron-exposed murine macrophages have a modified bactericidal activity as shown by previous observations. In order to assess the role of iron in macrophage activation, as measured by free radical production and by intracellular bacterial killing, murine peritoneal macrophages were cultivated in the presence of various sources of iron, human iron-saturated transferrin and ammonium ferric citrate, or iron chelators, Desferal, and human Apo-transferrin, and were infected with an enteropathogenic strain of E. coli. The release of nitrite (NO2-), and the production of superoxide anion (O2-) and hydrogen peroxide (H2O2) by the phagocytes were measured and compared to the production by uninfected macrophages. The synergistic action with murine r.IFN-gamma was also studied in the radical production reaction and for the bactericidal activity of macrophages. Our results show that in vitro phagocytosis of E. coli induced elevated production of NO2- and H2O2 by macrophages, and that oxygen derivatives were released independently of the presence of added iron or chelator. Despite a phagocytosis-related enhancement of NO2- release, reactive nitrogen intermediates (RNI) are not directly involved in the bactericidal mechanism, as revealed by increased intracellular killing owing to RNI inhibitors. Moreover, bacterial killing may depend on oxygen derivatives, as suggested by the effect of the antioxidant sodium ascorbate leading to both a diminished H2O2 production and a decreased bactericidal activity of macrophages.
Gauthier
Y P
YP
Unité de Microbiologie, Centre de Recherche du Service de Santé des Armées, La Tronche, France.
Isoard
P
P
D000818:Animals; D001059:Apoproteins / Q000494:pharmacology; D002478:Cells, Cultured; D003676:Deferoxamine / Q000494:pharmacology; D004926:Escherichia coli; D005290:Ferric Compounds / Q000494:pharmacology; D016166:Free Radical Scavengers / Q000494:pharmacology; D006801:Humans; D006861:Hydrogen Peroxide / Q000378:metabolism; D007501:Iron / Q000494:pharmacology*; D007502:Iron Chelating Agents / Q000494:pharmacology*; D008262:Macrophage Activation; D017737:Macrophages, Peritoneal / Q000187:drug effects / Q000502:physiology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008808:Mice, Inbred CBA; D009573:Nitrites / Q000378:metabolism; D010587:Phagocytosis; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D013481:Superoxides / Q000378:metabolism; D014168:Transferrin / Q000494:pharmacology
D001059:Apoproteins; D005290:Ferric Compounds; D016166:Free Radical Scavengers; D007502:Iron Chelating Agents; D009573:Nitrites; D000644:Quaternary Ammonium Compounds; D014168:Transferrin; C028284:apotransferrin; D013481:Superoxides; D006861:Hydrogen Peroxide; D007501:Iron; D003676:Deferoxamine; C013531:ferric ammonium citrate